Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDiploma Regulatory News (DPLM)

Share Price Information for Diploma (DPLM)

Share Price is delayed by 15 minutes
Get Live Data
7,130.00    80.00 (1.13%)
Bid:
7,110.00
Ask:
7,120.00
Spread: 10.00 (0.141%)
Market Cap: £9.56b
DPLM Live PriceLast checked at - London Stock Exchange

Intraday Diploma Share Chart

Trading Statement

27 Aug 2020 07:00

RNS Number : 2501X
Diploma PLC
27 August 2020
 

 

DIPLOMA PLC

12 CHARTERHOUSE SQUARE, LONDON EC1M 6AX

TELEPHONE: +44 (0)20 7549 5700

FACSIMILE: +44 (0)20 7549 5715

 

FOR IMMEDIATE RELEASE

 

27 August 2020

 

DIPLOMA PLC

 

PRE-YEAR-END TRADING UPDATE

 

TRADING LEVELS RECOVERING WELL

 

Diploma PLC, the international group supplying specialised technical products and services, today issues a trading update for the year ending 30 September 2020.

 

Johnny Thomson, Diploma's Chief Executive Officer said:

 

"Our businesses have responded exceptionally to the COVID-19 crisis, making a difference to our colleagues, our customers and our communities through these uncertain times. Diploma has also delivered a resilient trading performance, with revenues continuing to improve across all of our Sectors, and strong profit and cash generation throughout the period. Whilst the outlook for the virus remains uncertain, we are trading in line with expectations and are confident about the Group's growth prospects. The crisis has demonstrated the power of our value-add distribution model, the diversity of our end segments, the benefits of broad-based scalable businesses, and the importance of a strong balance sheet. Our strategy will continue to develop these strengths and we have significant market opportunities for growth." 

 

COVID-19 update

The Group continues to prioritise the wellbeing of our colleagues, whether at home or in the workplace. Operational working practices have been successfully adjusted to ensure a safe environment and the Group's decentralised model supports agile responses from local businesses to the unique circumstances in their location.

 

The Group prudently took part in the UK government's Job Retention Scheme given the highly uncertain market outlook at the outset of the crisis. However, by the end of June all furloughed colleagues had returned to work. In light of the resilience of the Group's performance through the crisis, we have now repaid all UK government support funds.

 

Group

The Group has delivered a resilient trading performance and adjusted operating profit for the full year is expected to be in line with market expectations. The Group's third quarter, running from April to June 2020, was impacted by the COVID-19 crisis with revenues down 12% on a reported basis and down 21% on an underlying basis. Performance started to recover in June and has continued into the fourth quarter, with revenues steadily improving in July, down 4% on a reported basis and down 10% on an underlying basis.

The following table sets out the year-on-year revenue change by Sector for the third quarter and separately for July:

 

Sector performance

Q3

July

Life Sciences

Underlying

-19%

-6%

 

Reported

-18%

-10%

 

 

 

 

Seals

Underlying

-12%

-7%

 

Reported

+9%

+10%

 

 

 

 

Controls

Underlying

-34%

-17%

 

Reported

-31%

-15%

 

 

 

 

Group

Underlying

-21%

-10%

 

Reported

-12%

-4%

 

 

Life Sciences

As expected, demand began to recover from the end of Q3 with the easing of lockdowns as hospitals re-opened for general activity and non-COVID-19 screening programmes were restarted. While the pace of recovery may be impacted by localised lockdowns, performance in the Life Sciences Sector is positive and improving.

 

Seals

Seals has delivered a resilient performance through the COVID-19 crisis, particularly in the North American Aftermarket and the International Seals businesses, both of which have benefitted from strong market positions and the diversity of our end customers. The Industrial OEM business has been more impacted by COVID-19 but is starting to recover. VSP, acquired in the US a year ago and the Group's largest acquisition to date, has delivered an excellent performance following its integration into the Group.

 

Controls

The Controls Sector has been most impacted by COVID-19, particularly in the Civil Aerospace segment which accounts for ca. 20% of Controls revenue (ca. 6% of Group revenue). Whilst Civil Aerospace remains challenging, the majority of our Controls businesses are recovering well.

 

Financial position

We continue to restrict all discretionary capital expenditure, focus on working capital to conserve cash, and are keeping tight control of expenses. The Group's balance sheet is strong and we expect net debt to be around neutral at the year-end. The Group has liquidity of around £100m through both its £60m revolving credit facility (undrawn) and available cash balances.

 

Acquisitions

Acquisitions remain a core part of the Group's strategy. During the year £13.6m has been spent on acquisitions. Whilst the COVID-19 crisis has made it more difficult to execute transactions, the pipeline of opportunities is encouraging. Diploma has a strong balance sheet and is well positioned to take advantage of opportunities. We are optimistic about bringing further high-quality, scalable businesses into the Group that will accelerate the growth strategy in our core markets.

  

 

 

 

 

 

Notes:

 

1. This trading update is based upon unaudited management accounts and has been prepared solely to provide additional information on trading to the shareholders of Diploma PLC. It should not be relied on by any other party for other purposes. Certain statements made in this update are forward-looking statements. Such statements have been made by the Directors in good faith using information available up until the date that they approved this Statement. Forward-looking statements should be regarded with caution because of the inherent uncertainties in economic trends and business risks.

 

2. Diploma PLC uses alternative performance measures as key financial indicators to assess the underlying performance of the Group. All references in this Statement to "underlying" revenues refer to reported results on a constant currency basis and before any contribution from acquired or disposed businesses.

 

3. A copy of this Statement, together with further information about Diploma PLC, may be viewed on its website at www.diplomaplc.com

 

Diploma PLC -

Johnny Thomson, Chief Executive Officer

+44 (0)20 7549 5700

Barbara Gibbes, Chief Financial Officer

 

 

 

 

 

Tulchan Communications -

+44 (0)20 7353 4200

Martin Robinson

 

Olivia Peters

 

 

 

 

 

 

 

NOTE TO EDITORS:

 

Diploma PLC is an international group supplying specialised products and services to a wide range of end segments in our three Sectors of Life Sciences, Seals and Controls.

 

Diploma's businesses are focussed on supplying essential products and services which are funded by the customers' operating rather than their capital budgets, providing recurring income and stable revenue growth.

 

Our businesses then design their individual business models to closely meet the requirements of their customers, offering a blend of high quality customer service, deep technical support and value adding activities. By supplying essential solutions, not just products, we build strong long term relationships with our customers and suppliers, which support attractive and sustainable margins.

 

Finally we encourage an entrepreneurial culture in our businesses through our decentralised management structure. We want our managers to feel that they have the freedom to run their own businesses, while being able to draw on the support and resources of a larger group. These essential values ensure that decisions are made close to the customer and that the businesses are agile and responsive to changes in the market and the competitive environment. The Group employs ca. 2,100 employees and its principal operating businesses are located in the UK, Northern Europe, North America and Australia.

 

Over the last ten years, the Group has grown adjusted earnings per share at an average of ca. 16% p.a. through a combination of underlying growth and acquisitions. Diploma is a member of the FTSE 250 with a market capitalisation of ca. £2.2bn.

 

Further information on Diploma PLC can be found at www.diplomaplc.com

 

 

 

LEI: 2138008OGI7VYG8FGR19

 

 

 

 

 

 

 

 

 

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTPPURWRUPUGAQ
Date   Source Headline
1st Jun 20264:00 pmRNSAppointment of Non-Executive Director
21st May 20265:01 pmRNSDirector/PDMR Shareholding
19th May 20267:00 amRNSHalf Year Results
20th Apr 20265:33 pmRNSHolding(s) in Company
9th Apr 20261:16 pmRNSHolding(s) in Company
23rd Mar 20263:02 pmRNSDirector/PDMR Shareholding
18th Mar 20267:00 amRNSSignificant upgrade to FY26 guidance
27th Feb 20261:45 pmRNSAppointment of Non-Executive Director
27th Jan 20264:06 pmRNSHolding(s) in Company
16th Jan 20263:05 pmRNSDirector/PDMR Shareholding
15th Jan 202610:30 amRNSDirector/PDMR Shareholding
14th Jan 20263:53 pmRNSResult of AGM
14th Jan 20267:00 amRNSQ1 2026 Trading Update
22nd Dec 20257:00 amRNSDirector/PDMR Shareholding
22nd Dec 20257:00 amRNSDirector/PDMR Shareholding
19th Dec 20251:33 pmRNSHolding(s) in Company
19th Dec 20251:33 pmRNSHolding(s) in Company
18th Dec 202510:52 amRNSHolding(s) in Company
17th Dec 20257:00 amRNSChief Financial Officer appointment
8th Dec 20257:00 amRNSAnnual Financial Report & Notice of AGM
1st Dec 20257:00 amRNSTotal Voting Rights
26th Nov 20257:00 amRNSDirector/PDMR Grant of LTIP Awards
19th Nov 20252:17 pmRNSDirector/PDMR Shareholding
19th Nov 20257:00 amRNSDirector/PDMR Shareholding
18th Nov 20257:00 amRNSPreliminary Results
13th Nov 20257:00 amRNSIssue of Shares & Total Voting Rights
7th Oct 20257:00 amRNSDirector Declaration
2nd Oct 20252:41 pmRNSHolding(s) in Company
14th Aug 20257:00 amRNSChief Financial Officer update
17th Jul 20257:00 amRNSQ3 Trading Update
2nd Jul 20259:49 amRNSHolding(s) in Company
20th Jun 20259:50 amRNSHolding(s) in Company
9th Jun 202512:50 pmRNSHolding(s) in Company
28th May 20259:27 amRNSHolding(s) in Company
21st May 20254:07 pmRNSDirector/PDMR Shareholding
20th May 20257:00 amRNSHalf-year Report
19th May 202511:02 amRNSHolding(s) in Company
19th May 202510:57 amRNSHolding(s) in Company
9th May 20254:24 pmRNSHolding(s) in Company
6th May 20259:32 amRNSHolding(s) in Company
11th Apr 20253:44 pmRNSHolding(s) in Company
3rd Apr 20257:03 amRNSDirector Declaration
25th Mar 20257:00 amRNSDirector/PDMR Shareholding
24th Mar 20259:36 amRNSHolding(s) in Company
24th Mar 20257:00 amRNSDirector/PDMR Shareholding
24th Mar 20257:00 amRNSDirector/PDMR Shareholding
18th Mar 20259:54 amRNSHolding(s) in Company
3rd Mar 202510:15 amRNSDirector Declaration - External Appointment
25th Feb 20257:00 amRNSHolding(s) in Company
14th Feb 20253:20 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.